TabletsTablets
Schedule H (Prescription Required)Contraceptives & Hormonal TherapyCode: 733

Progesterone Sustained Release Tablets 200 mg

Generic Formulation:Progesterone Sustained Release Tablets 200 mg
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹152.81
Brand Estimate*
₹438.99
Estimated Savings:₹286.18 (65% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Progesterone (Sustained Release Tablets 200mg) is a bioidentical progestogen on the WHO Model List of Essential Medicines. Identical to human ovarian luteal progesterone, it transforms the proliferative endometrium into a secretory endometrium, promotes blastocyst implantation, suppresses myometrial oxytocin receptor expression, and inhibits uterine contractions to maintain pregnancy. Indicated for luteal phase support in assisted reproduction (IVF/ICSI), threatened and recurrent miscarriage, prevention of preterm birth in women with short cervix, secondary amenorrhea, and endometrial protection during estrogen HRT.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 733.Report inaccuracy

Usage Guidelines

Take orally 200 mg once or twice daily with water. Sustained-release tablet provides smooth 24-hour therapeutic plasma levels. Swallow whole; do NOT crush or chew. Take preferably with or immediately after food at bedtime to minimize daytime somnolence.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Drowsiness/somnolence (oral route), dizziness, headache, breast tenderness, abdominal bloating, nausea, and vaginal discharge/leakage (vaginal route). Rare/Severe: Thromboembolic events (DVT, PE), cholestatic jaundice, depression, and severe allergic reactions.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Use caution when driving or operating machinery due to central sedative metabolites (allopregnanolone) when taken orally. Contraindicated in active venous thromboembolism, severe hepatic impairment, undiagnosed vaginal bleeding, porphyria, and missed abortion. Safe and indicated during early pregnancy under specialist care.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Gynecological, Obstetric & Endocrinological Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice or reproductive healthcare guidance. Hormonal medications, uterotonics, corticosteroids, fertility therapies, and emergency contraceptives have profound systemic actions and must be administered strictly under the supervision of a registered gynecologist, obstetrician, or endocrinologist.